, /PRNewswire/ -- and The Institute of Advanced Ultrasound Guided Procedures announced today that ECRI completed a of its UltraGuideCTRTM, with an Evidence Bar rating of "Favorable." The ECRI Evidence Bar is a visualization of the organization's judgment about the balance of benefits and harms of technology after assessing the available published clinical evidence in light of key outcomes and comparisons of interest. ECRI's Clinical Evidence Assessment concluded that UltraGuideCTR is safe and improves functional status and symptom severity in patients with carpal tunnel syndrome (CTS), based on consistent findings from one randomized controlled trial and eight before-and-after studies reported in 11 publications.
The full report is available to ECRI members. "The ECRI Evidence Bar Favorable rating is a significant milestone supporting the safety and effectiveness of UltraGuideCTR," said Sonex Health CEO . "This report provides payers and healthcare providers with access to a valuable summary of the breadth and depth of the UltraGuideCTR clinical outcomes data.
" More than 31,000 carpal tunnel release with ultrasound guidance (CTR-US) procedures have been performed by over 200 physicians in 41 states, with another 52 physicians actively training to perform these procedures. In addition, more than 800 hand surgeons have participated in a variety of educational program opportunities sponsored by Sonex Health and The Institute of Advanced Ultrasound Guided Procedures, including a .
